iShares Genomics Immunology and Healthcare ETF (IDNA) is an ETF managed by BlackRock / iShares. Its largest position is BLACKROCK FUNDS III (BISXX), representing 20.98% of fund assets.
iShares Genomics Immunology and Healthcare ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- IDNA
- Type:
- ETF
- Manager:
- BlackRock / iShares
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 25, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
BLACKROCK FUNDS III
|
20.98% | $33,673,050.88 | 33,662,952 |
|
-
Revolution Medicines, Inc.
|
6.85% | $10,999,959.00 | 76,325 |
|
-
Moderna, Inc.
|
6.28% | $10,081,119.54 | 219,441 |
|
-
APPLIED MATERIALS INC /DE
|
5.24% | $8,407,956.29 | 42,810 |
|
-
APPLIED MATERIALS INC /DE
|
4.38% | $7,025,573.91 | 156,689 |
|
-
TAKEDA PHARMACEUTICAL CO LTD
|
4.22% | $6,770,138.30 | 202,500 |
|
-
Merck & Co., Inc.
|
4.15% | $6,655,176.08 | 60,956 |
|
-
GSK plc
|
4.12% | $6,617,210.65 | 252,397 |
|
-
BioNTech SE
|
4.07% | $6,533,177.85 | 63,153 |
|
-
APPLIED MATERIALS INC /DE
|
3.99% | $6,407,527.48 | 15,724 |
|
-
EXELIXIS, INC.
|
3.80% | $6,092,220.42 | 137,027 |
|
-
Twist Bioscience Corp
|
3.79% | $6,075,059.20 | 103,936 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
3.73% | $5,983,141.72 | 8,462 |
|
-
APPLIED MATERIALS INC /DE
|
3.58% | $5,745,032.66 | 61,394 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
3.55% | $5,703,386.10 | 13,345 |
|
-
INCYTE CORP
|
3.52% | $5,648,653.57 | 59,291 |
|
-
GENMAB A/S
|
3.16% | $5,078,941.73 | 19,182 |
|
-
IDEAYA Biosciences, Inc.
|
2.71% | $4,348,529.40 | 149,434 |
|
-
ImmunityBio, Inc.
|
2.61% | $4,188,574.00 | 589,940 |
|
-
Caris Life Sciences, Inc.
|
2.44% | $3,907,749.00 | 205,671 |
|
-
Arcus Biosciences, Inc.
|
2.12% | $3,406,774.50 | 133,599 |
|
-
APPLIED MATERIALS INC /DE
|
1.86% | $2,992,048.79 | 202,300 |
|
-
CRISPR Therapeutics AG
|
1.80% | $2,896,286.24 | 55,336 |
|
-
NOVAVAX INC
|
1.31% | $2,096,257.60 | 264,512 |
|
-
IOVANCE BIOTHERAPEUTICS, INC.
|
1.24% | $1,995,450.24 | 593,884 |
|
-
GENFLEET THERAPEUTICS SHANGHAI INC
|
1.20% | $1,922,242.57 | 345,600 |
|
-
Nuvation Bio Inc.
|
1.18% | $1,898,556.90 | 426,642 |
|
-
Vir Biotechnology, Inc.
|
1.07% | $1,711,747.98 | 167,572 |
|
-
AbCellera Biologics Inc.
|
1.06% | $1,706,849.35 | 411,289 |
|
-
Corvus Pharmaceuticals, Inc.
|
0.97% | $1,551,931.92 | 102,168 |
|
-
Janux Therapeutics, Inc.
|
0.86% | $1,378,700.91 | 95,943 |
|
-
Kura Oncology, Inc.
|
0.83% | $1,328,650.10 | 150,470 |
|
-
SUNSHINE LAKE PHARMA CO LTD
|
0.62% | $1,001,159.78 | 190,700 |
|
-
CytomX Therapeutics, Inc.
|
0.60% | $962,324.58 | 228,039 |
|
-
Ocugen, Inc.
|
0.59% | $949,233.70 | 548,690 |
|
-
RIGEL PHARMACEUTICALS INC
|
0.57% | $910,725.70 | 31,513 |
|
-
ABCLON INC.
|
0.56% | $903,674.33 | 27,030 |
|
-
Intellia Therapeutics, Inc.
|
0.56% | $897,673.64 | 66,593 |
|
-
APPLIED MATERIALS INC /DE
|
0.50% | $805,577.25 | 83,900 |
|
-
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
|
0.48% | $768,008.16 | 483,024 |
|
-
Design Therapeutics, Inc.
|
0.47% | $758,349.60 | 55,761 |
|
-
Valneva SE
|
0.44% | $705,395.20 | 258,253 |
|
-
Ginkgo Bioworks Holdings, Inc.
|
0.40% | $636,978.78 | 75,293 |
|
-
Verastem, Inc.
|
0.40% | $634,866.96 | 116,276 |
|
-
Alvotech
|
0.39% | $629,185.86 | 188,379 |
|
-
Personalis, Inc.
|
0.33% | $522,578.40 | 94,670 |
|
-
Xencor Inc
|
0.30% | $484,882.92 | 40,644 |
|
-
GUANGZHOU INNOGEN PHARMACEUTICAL GROUP CO LTD
|
0.13% | $214,848.39 | 120,200 |
|
-
Prime Medicine, Inc.
|
0.13% | $201,519.07 | 56,846 |
|
-
APPLIED MATERIALS INC /DE
|
0.04% | $65,622.26 | 55,913 |
Advertisement (320x50)